Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | MEXER | 3,166 | — | — | +100.0% | Open the original filing on SEC.gov |
| Oct 28, 2025 | TRML | Tourmaline Bio, Inc. | DTOISS◆ | 16,800 | — | — | — | Open the original filing on SEC.gov |
| Oct 28, 2025 | TRML | Tourmaline Bio, Inc. | DTOISS◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 28, 2025 | TRML | Tourmaline Bio, Inc. | UTENDR | 88,281 | — | — | -100.0% | Open the original filing on SEC.gov |
| Oct 24, 2025 | TRML | Tourmaline Bio, Inc. | GGIFT | 5,000 | — | — | -5.4% | Open the original filing on SEC.gov |
| Sep 5, 2025 | TRML | Tourmaline Bio, Inc. | MEXER◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 5, 2025 | TRML | Tourmaline Bio, Inc. | MEXER◆ | 37,890 | — | — | — | Open the original filing on SEC.gov |
| Sep 5, 2025 | TRML | Tourmaline Bio, Inc. | MEXER | 10,000 | $9.46 | $94.6K | +12.0% | Open the original filing on SEC.gov |
| Sep 5, 2025 | TRML | Tourmaline Bio, Inc. | MEXER | 37,890 | $0.13 | $4.9K | +83.5% | Open the original filing on SEC.gov |
| Jun 17, 2025 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 20,100 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | TRML | Tourmaline Bio, Inc. | AGRANT◆ | 16,800 | — | — | — | Open the original filing on SEC.gov |